108 related articles for article (PubMed ID: 17661479)
1. Depolymerized products of lambda-carrageenan as a potent angiogenesis inhibitor.
Chen H; Yan X; Lin J; Wang F; Xu W
J Agric Food Chem; 2007 Aug; 55(17):6910-7. PubMed ID: 17661479
[TBL] [Abstract][Full Text] [Related]
2. [In vitro anti-angiogenic action of lambda-carrageenan oligosaccharides].
Chen HM; Yan XJ; Wang F; Lin J; Xu WF
Yao Xue Xue Bao; 2007 Jun; 42(6):595-600. PubMed ID: 17702394
[TBL] [Abstract][Full Text] [Related]
3. [Proliferation inhibition of lambda-carrageenan oligosaccharides on HUVEC and expression of apoptotic relevant genes].
Mi TY; Yan XJ; Chen HM; Lin J; Wang F; Xu WF
Yao Xue Xue Bao; 2008 May; 43(5):474-9. PubMed ID: 18717333
[TBL] [Abstract][Full Text] [Related]
4. Anti-angiogenic effects of a nutrient mixture on human umbilical vein endothelial cells.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Oncol Rep; 2005 Dec; 14(6):1399-404. PubMed ID: 16273231
[TBL] [Abstract][Full Text] [Related]
5. [Expression and biological activity of human angiogenesis inhibitor angiostatin in insect cells].
Xu XL; Liu GF; Huang DY
Ai Zheng; 2005 Sep; 24(9):1096-101. PubMed ID: 16159432
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo.
Mannell H; Hellwig N; Gloe T; Plank C; Sohn HY; Groesser L; Walzog B; Pohl U; Krotz F
J Vasc Res; 2008; 45(2):153-63. PubMed ID: 17962719
[TBL] [Abstract][Full Text] [Related]
7. [Carrageenan oligosaccharides inhibit growth-factor binding and heparanase activity].
Chen HM; Gao Y; Yan XJ
Yao Xue Xue Bao; 2011 Mar; 46(3):280-4. PubMed ID: 21626781
[TBL] [Abstract][Full Text] [Related]
8. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of tumor angiogenesis by targeting endothelial surface ATP synthase with sangivamycin.
Komi Y; Ohno O; Suzuki Y; Shimamura M; Shimokado K; Umezawa K; Kojima S
Jpn J Clin Oncol; 2007 Nov; 37(11):867-73. PubMed ID: 17956898
[TBL] [Abstract][Full Text] [Related]
10. Identification of campesterol from Chrysanthemum coronarium L. and its antiangiogenic activities.
Choi JM; Lee EO; Lee HJ; Kim KH; Ahn KS; Shim BS; Kim NI; Song MC; Baek NI; Kim SH
Phytother Res; 2007 Oct; 21(10):954-9. PubMed ID: 17604370
[TBL] [Abstract][Full Text] [Related]
11. [Effects of triptolide on anti-angiogenesis by reducing expression of urokinase plasminogen activator].
Ding Y; Zhang J; Hou L; Zhang J; Wang Q; Wang S
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Aug; 22(4):778-81. PubMed ID: 16156271
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the antiangiogenic, anti-inflammatory, and antinociceptive activities of morin.
Jung HJ; Kim SJ; Song YS; Park EH; Lim CJ
Planta Med; 2010 Feb; 76(3):273-5. PubMed ID: 19774509
[TBL] [Abstract][Full Text] [Related]
13. Alternative splicing of vasohibin-1 generates an inhibitor of endothelial cell proliferation, migration, and capillary tube formation.
Kern J; Bauer M; Rychli K; Wojta J; Ritsch A; Gastl G; Gunsilius E; Untergasser G
Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):478-84. PubMed ID: 18187668
[TBL] [Abstract][Full Text] [Related]
14. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of endothelial cell differentiation and proinflammatory cytokine production during angiogenesis by allyl isothiocyanate and phenyl isothiocyanate.
Thejass P; Kuttan G
Integr Cancer Ther; 2007 Dec; 6(4):389-99. PubMed ID: 18048887
[TBL] [Abstract][Full Text] [Related]
16. The anti-angiogenic effects of 1-furan-2-yl-3-pyridin-2-yl-propenone are mediated through the suppression of both VEGF production and VEGF-induced signaling.
Park BC; Park SY; Lee JS; Mousa SA; Kim JT; Kwak MK; Kang KW; Lee ES; Choi HG; Yong CS; Kim JA
Vascul Pharmacol; 2009; 50(3-4):123-31. PubMed ID: 19068239
[TBL] [Abstract][Full Text] [Related]
17. Friend erythroleukemia cells induce angiogenesis in chick embryo chorioallantoic membrane and in human umbilical vein endothelial cells.
Pacini S; Punzi T; Gulisano M; Ruggiero M
Biol Res; 2008; 41(1):109-17. PubMed ID: 18769768
[TBL] [Abstract][Full Text] [Related]
18. Beta-carotene inhibits tumor-specific angiogenesis by altering the cytokine profile and inhibits the nuclear translocation of transcription factors in B16F-10 melanoma cells.
Guruvayoorappan C; Kuttan G
Integr Cancer Ther; 2007 Sep; 6(3):258-70. PubMed ID: 17761639
[TBL] [Abstract][Full Text] [Related]
19. Juice of eclipta prostrata inhibits cell migration in vitro and exhibits anti-angiogenic activity in vivo.
Lirdprapamongkol K; Kramb JP; Chokchaichamnankit D; Srisomsap C; Surarit R; Sila-Asna M; Bunyaratvej A; Dannhardt G; Svasti J
In Vivo; 2008; 22(3):363-8. PubMed ID: 18610749
[TBL] [Abstract][Full Text] [Related]
20. Enzymatic preparation of κ-carrageenan oligosaccharides and their anti-angiogenic activity.
Yao Z; Wu H; Zhang S; Du Y
Carbohydr Polym; 2014 Jan; 101():359-67. PubMed ID: 24299784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
